Analysis through the DDD study subsequently identified a pathogenic heterozygous SMC3 variant, establishing a concurrent diagnosis of Cornelia de Lange syndrome, over a decade later, in April 2024, consistent with the previously unexplained features. This evidence concerns the gene SMC3 and Cornelia de Lange syndrome.